Abstract

Background

Antibiotic use (ABU) surveillance in healthcare facilities (HCFs) is essential to guide stewardship. Two methods are recommended: antibiotic consumption (ABC), expressed as the number of DDD/1000 patient-days; and prevalence of antibiotic prescription (ABP) measured through point prevalence surveys. However, no evidence is provided about whether they lead to similar conclusions.

Objectives

To compare ABC and ABP regarding HCF ranking and their ability to identify outliers.

Methods

The comparison was made using 2012 national databases from the antibiotic surveillance network and prevalence study. HCF rankings according to each method were compared with Spearman’s correlation coefficient. Analyses included the ABU from entire HCFs as well as according to type, clinical ward and by antibiotic class and specific molecule.

Results

A total of 1076 HCFs were included. HCF rankings were strongly correlated in the whole cohort. The correlation was stronger for HCFs with a higher number of beds or with a low or moderate proportion of acute care beds. ABU correlation between ABC or ABP was globally moderate or weak in specific wards. Furthermore, the two methods did not identify the same outliers, whichever HCF characteristics were analysed. Correlation between HCF ranking varied according to the antibiotic class.

Conclusions

Both methods ranked HCFs similarly overall according to ABC or ABP; however, major differences were observed in ranking of clinical wards, antibiotic classes and detection of outliers. ABC and ABP are two markers of ABU that could be used as two complementary approaches to identify targets for improvement.

Details

Title
How to measure hospital antibiotic consumption: comparison of two methods from data surveillance in France
Author
Stordeur, Florence 1   VIAFID ORCID Logo  ; Katiuska Miliani 2 ; Lacavé, Ludivine 3 ; Rogues, Anne-Marie 4 ; Dumartin, Catherine 5 ; Alfandari, Serge 6 ; Astagneau, Pascal 7 ; François L’Hériteau 2 

 Centre hospitalier intercommunal de Poissy St Germain, 10 rue du champ Gaillard, 78100 Poissy, France 
 Centre d’appui pour la prévention des infections associées aux soins (CPias) Ile-de-France, Paris, France 
 Assistance Publique – Hôpitaux de Paris (AP-HP), délégation à la recherche clinique et à l’innovation (DRCI), Paris, France 
 Université Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France; CHU Bordeaux, Hygiène hospitalière, F-33000 Bordeaux, France 
 Université Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France; CHU Bordeaux, CPias Nouvelle Aquitaine, F-33000 Bordeaux, France 
 Centre Hospitalier de Tourcoing, 59208 Tourcoing, France 
 Centre d’appui pour la prévention des infections associées aux soins (CPias) Ile-de-France, Paris, France; Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, F-75013 Paris, France 
Publication year
2020
Publication date
Sep 2020
Publisher
Oxford University Press
e-ISSN
26321823
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3169989851
Copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.